BI-Heteroaryl Substitute 1,4-Benzodiazepines And Uses Thereof For The Treatment Of Cancer
The invention relates to new quinoline, pyridopyrazine, naphthyridine and quinazolinone derivative compounds, to pharmaceutical compositions comprising said compounds, to processes for the preparation of said compounds and to the use of said compounds in the treatment of diseases, e.g. cancer.
Saved in:
Main Authors | , , , , , , |
---|---|
Format | Patent |
Language | English |
Published |
29.06.2023
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The invention relates to new quinoline, pyridopyrazine, naphthyridine and quinazolinone derivative compounds, to pharmaceutical compositions comprising said compounds, to processes for the preparation of said compounds and to the use of said compounds in the treatment of diseases, e.g. cancer. |
---|---|
Bibliography: | Application Number: US202218084092 |